Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Ferdinando D'Amico and Silvio Danese.
Ferdinando D'Amico
Connection Strength
9.186
Silvio Danese
  1. SARS-CoV-2 vaccination in IBD: more pros than cons. Nat Rev Gastroenterol Hepatol. 2021 04; 18(4):211-213.
    View in: PubMed
    Score: 0.938
  2. Reply. Gastroenterology. 2021 05; 160(6):2223-2224.
    View in: PubMed
    Score: 0.928
  3. Oral Iron for IBD Patients: Lessons Learned at Time of COVID-19 Pandemic. J Clin Med. 2020 May 19; 9(5).
    View in: PubMed
    Score: 0.883
  4. Views of patients with inflammatory bowel disease on the COVID-19 pandemic: a global survey. Lancet Gastroenterol Hepatol. 2020 07; 5(7):631-632.
    View in: PubMed
    Score: 0.882
  5. Inflammatory Bowel Diseases and COVID-19: The Invisible Enemy. Gastroenterology. 2020 Jun; 158(8):2302-2304.
    View in: PubMed
    Score: 0.877
  6. Tofacitinib in the treatment of ulcerative colitis: efficacy and safety from clinical trials to real-world experience. Therap Adv Gastroenterol. 2019; 12:1756284819848631.
    View in: PubMed
    Score: 0.823
  7. Vedolizumab for the treatment of inflammatory bowel diseases: from symptomatic control to mucosal healing. Immunotherapy. 2019 05; 11(7):565-575.
    View in: PubMed
    Score: 0.813
  8. Janus kinase inhibitors for the treatment of inflammatory bowel diseases: developments from phase I and phase II clinical trials. Expert Opin Investig Drugs. 2018 07; 27(7):595-599.
    View in: PubMed
    Score: 0.775
  9. IBD goes home: from telemedicine to self-administered advanced therapies. Expert Opin Biol Ther. 2022 01; 22(1):17-29.
    View in: PubMed
    Score: 0.238
  10. Setting up a Virtual Calprotectin Clinic in Inflammatory Bowel Diseases: Literature Review and Nancy Experience. J Clin Med. 2020 Aug 20; 9(9).
    View in: PubMed
    Score: 0.225
  11. Systematic Review on Inflammatory Bowel Disease Patients With Coronavirus Disease 2019: It Is Time to Take Stock. Clin Gastroenterol Hepatol. 2020 11; 18(12):2689-2700.
    View in: PubMed
    Score: 0.224
  12. Reply. Clin Gastroenterol Hepatol. 2020 12; 18(13):3055.
    View in: PubMed
    Score: 0.222
  13. Inflammatory Bowel Disease Management During the Coronavirus-19 Outbreak: A Survey From the European Crohn's and Colitis Organization. Gastroenterology. 2020 Jul; 159(1):14-19.e3.
    View in: PubMed
    Score: 0.220
  14. Maintaining the Quality Standards of Care for Inflammatory Bowel Disease Patients During the COVID-19 Pandemic. Clin Gastroenterol Hepatol. 2020 07; 18(8):1882-1883.
    View in: PubMed
    Score: 0.219
  15. Diarrhea During COVID-19 Infection: Pathogenesis, Epidemiology, Prevention, and Management. Clin Gastroenterol Hepatol. 2020 07; 18(8):1663-1672.
    View in: PubMed
    Score: 0.219
  16. Unmet Needs in IBD: the Case of Fatigue. Clin Rev Allergy Immunol. 2018 Dec; 55(3):368-378.
    View in: PubMed
    Score: 0.199
  17. Positioning Tofacitinib in the Treatment Algorithm of Moderate to Severe Ulcerative Colitis. Inflamm Bowel Dis. 2018 09 15; 24(10):2106-2112.
    View in: PubMed
    Score: 0.196
  18. JAK inhibitors: Novel developments in management of ulcerative colitis. Best Pract Res Clin Gastroenterol. 2018 Feb - Apr; 32-33:89-93.
    View in: PubMed
    Score: 0.192
  19. Patients with Inflammatory Bowel Disease Are Not at Increased Risk of COVID-19: A Large Multinational Cohort Study. J Clin Med. 2020 Oct 31; 9(11).
    View in: PubMed
    Score: 0.057
  20. SFED recommendations for IBD endoscopy during COVID-19 pandemic: Italian and French experience. Nat Rev Gastroenterol Hepatol. 2020 08; 17(8):507-516.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.